New York, NY (PRWEB) April 24, 2013
The hip implant safety advocates at DrugRisks.com are announcing updated information on the site for patients who received the recalled Stryker Rejuvenate or ABG II hip systems. The site notes a recent court order that could help move cases alleging injury towards settlement.
The goal of DrugRisks is to improve the safety of patients using popular medical devices and prescription drugs by providing the latest warnings, recalls, studies and litigation news. Visitors can see if others are experiencing similar side effects and decide whether they need legal advice.
The resource center contains warnings from the British Medical Journal* and FDA** that toxic metal shavings from all-metal hips like the Stryker ABG II and Rejuvenate can cause serious conditions such as metallic poisoning, tissue damage, bone loss and damage to other organs.
Last year, Stryker recalled the Rejuvenate and ABG II hip implants, admitting that some patients have experienced effects like adverse tissue reaction and elevated metallic blood levels, even when no symptoms are present***.
Due to the number of patients who have filed a Stryker hip lawsuit, lawyers recently asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate them to a special federal court in the U.S. District Court, District of Minnesota. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML)).
On April 2nd, Bergen County Superior Court Judge Brian R. Martinotti, who is presiding over at least 80 Stryker hip recall lawsuits in a New Jersey multi-district court****, ordered parties to participate in mediation. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Anyone who received the recalle
Copyright©2012 Vocus, Inc.
All rights reserved